Literature DB >> 8308298

Riboprobe expression cassettes for measuring IGF-I, beta-actin and glyceraldehyde 3-phosphate dehydrogenase transcripts.

A Biragyn1, S Arkins, K W Kelley.   

Abstract

The development of riboprobe expression cassettes for phosphorimager-based quantitation of steady-state transcripts for three different genes using solution hybridization, RNase protection assays is described. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and beta-actin genes are widely used as reporter genes to estimate the amount and integrity of RNA as well as for comparing gene expression among different tissues. To directly compare expression of these two genes in lymphoid tissue and liver, cDNA fragments of beta-actin and GAPDH from both mice and rats were generated by RT-PCR and cloned together into pGEM1 under control of the T7 RNA polymerase promoter. Antisense transcripts from this fusion construct protected the appropriate-sized fragments of beta-actin (115 nt) and GAPDH (214 nt) in RNA isolated from rat spleen, thymus and liver. Expression of GAPDH transcripts was less variable across tissues because this mRNA was only two-fold lower in liver as compared to either thymus or spleen, whereas expression of beta-actin transcripts was eight-fold lower in liver than in these tissues. Two other riboprobe expression cassettes (IGF-I/actin) were constructed by ligating a cDNA fragment of mouse or rat beta-actin that would protect 115 nt to either a mouse or rat IGF-I genomic DNA fragment containing 182 bp of exon 4. These mouse and rat IGF-I/actin riboprobes were used to conclusively demonstrate that rat CSF-1-derived bone marrow macrophages, mouse elicited peritoneal macrophages and the murine PU5-1R macrophage cell line synthesize abundant transcripts for both IGF-I and beta-actin. However, the mouse M1 progenitor myeloid cell line does not express RNA for IGF-I, as demonstrated by the absence of protected transcripts for IGF-I in the presence of abundant protected transcripts for beta-actin. Phosphorimager scanning of the gels revealed that macrophages of both mice and rats express IGF-I transcripts at a level of 60-100% of those found in liver. These data show that a single riboprobe can be developed to generate multigene antisense RNAs that can then be used to quantitatively compare IGF-I transcripts in macrophages and other tissues to an internal standard, with GAPDH transcripts being less variable among tissues than those for beta-actin. This approach should be broadly applicable for measuring a variety of markers of cellular activation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8308298     DOI: 10.1016/0022-1759(94)90060-4

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  5 in total

1.  Cloning of the monocarboxylate transporter isoform MCT2 from rat testis provides evidence that expression in tissues is species-specific and may involve post-transcriptional regulation.

Authors:  V N Jackson; N T Price; L Carpenter; A P Halestrap
Journal:  Biochem J       Date:  1997-06-01       Impact factor: 3.857

2.  Human peripheral blood T regulatory cells (Tregs), functionally primed CCR4+ Tregs and unprimed CCR4- Tregs, regulate effector T cells using FasL.

Authors:  Dolgor Baatar; Purevdorj Olkhanud; Kenya Sumitomo; Dennis Taub; Ronald Gress; Arya Biragyn
Journal:  J Immunol       Date:  2007-04-15       Impact factor: 5.422

3.  Transport of lipophilic drug molecules in a new mucus-secreting cell culture model based on HT29-MTX cells.

Authors:  I Behrens; P Stenberg; P Artursson; T Kissel
Journal:  Pharm Res       Date:  2001-08       Impact factor: 4.200

4.  Sim2 mutants have developmental defects not overlapping with those of Sim1 mutants.

Authors:  Eleni Goshu; Hui Jin; Rachel Fasnacht; Mike Sepenski; Jacques L Michaud; Chen-Ming Fan
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

5.  Agrin controls synaptic differentiation in hippocampal neurons.

Authors:  C M Bose; D Qiu; A Bergamaschi; B Gravante; M Bossi; A Villa; F Rupp; A Malgaroli
Journal:  J Neurosci       Date:  2000-12-15       Impact factor: 6.167

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.